EAM
BVS icon

Empirical Asset Management’s Bioventus BVS Stock Holding History

Empirical Asset Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,608
Closed -$161K – 457
2026
Q1 		$161K Buy
+17,608
New +$148K 0.04% 380

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Empirical Asset Management's BVS Position: Q2 2026 in Review

Empirical Asset Management sold out of Bioventus (BVS) in Q2 2026, closing a stake of 17,608 shares — an estimated $161K sold.

Empirical Asset Management first reported a position in BVS in Q1 2026 and held it in 1 quarter. The position peaked at $161K in Q1 2026. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Empirical Asset Management reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
  • Empirical Asset Management sold 17,608 Bioventus shares in Q2 2026, an estimated $161K.
  • Empirical Asset Management first reported a position in Bioventus in Q1 2026 and held it in 1 quarter.
  • Empirical Asset Management's Bioventus position peaked at $161K in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.